Insilico Medicine’s Chemistry42 Drives Discovery of Novel Chemotype Pan-KRAS Inhibitors – ACS Medicinal Chemistry Letters
In a significant breakthrough that harnesses the cutting-edge capabilities of artificial intelligence (AI) in drug discovery, Insilico Medicine, a leading ...
